DK3082865T3 - Forebyggelse og modvirkning af kostinduceret tromboserisiko - Google Patents

Forebyggelse og modvirkning af kostinduceret tromboserisiko Download PDF

Info

Publication number
DK3082865T3
DK3082865T3 DK14816271.2T DK14816271T DK3082865T3 DK 3082865 T3 DK3082865 T3 DK 3082865T3 DK 14816271 T DK14816271 T DK 14816271T DK 3082865 T3 DK3082865 T3 DK 3082865T3
Authority
DK
Denmark
Prior art keywords
counterpact
diet
prevention
induced thrombosis
thrombosis risk
Prior art date
Application number
DK14816271.2T
Other languages
English (en)
Inventor
Cees Vermeer
Original Assignee
Nattopharma Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattopharma Asa filed Critical Nattopharma Asa
Application granted granted Critical
Publication of DK3082865T3 publication Critical patent/DK3082865T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14816271.2T 2013-12-20 2014-12-19 Forebyggelse og modvirkning af kostinduceret tromboserisiko DK3082865T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13198969.1A EP2886129A1 (en) 2013-12-20 2013-12-20 Prevention and counteraction of diet-induced thrombosis risk
PCT/EP2014/078866 WO2015092018A1 (en) 2013-12-20 2014-12-19 Prevention and counteraction of diet-induced thrombosis risk

Publications (1)

Publication Number Publication Date
DK3082865T3 true DK3082865T3 (da) 2021-11-15

Family

ID=49882890

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14816271.2T DK3082865T3 (da) 2013-12-20 2014-12-19 Forebyggelse og modvirkning af kostinduceret tromboserisiko

Country Status (8)

Country Link
US (1) US20160310445A1 (da)
EP (2) EP2886129A1 (da)
DK (1) DK3082865T3 (da)
ES (1) ES2896945T3 (da)
HU (1) HUE056231T2 (da)
PL (1) PL3082865T3 (da)
PT (1) PT3082865T (da)
WO (1) WO2015092018A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
AU2020236308A1 (en) * 2019-03-12 2021-11-04 Nattopharma As Use of vitamin K in combination with anticoagulants
EP4132488A1 (en) * 2020-04-09 2023-02-15 Emphysema Solutions BV Use of vitamin k in preventing or counteracting covid-19 disease and diagnostic test to estimate the risk of developing severe disease or mortality by covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
AU2007271900B2 (en) 2006-07-14 2013-05-23 Nattopharma As Pharmaceutical and nutraceutical products comprising vitamin K2
EP2178818B1 (en) * 2007-07-24 2020-09-09 Viridis Biopharma Pvt Ltd. Treatments using vitamin k analogues and derivatives
EP2709460A1 (en) * 2011-05-20 2014-03-26 Friesland Brands B.V. Composition comprising vitamin k2
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.

Also Published As

Publication number Publication date
PT3082865T (pt) 2021-11-16
EP3082865A1 (en) 2016-10-26
US20160310445A1 (en) 2016-10-27
HUE056231T2 (hu) 2022-02-28
PL3082865T3 (pl) 2021-12-27
EP3082865B1 (en) 2021-08-11
WO2015092018A1 (en) 2015-06-25
ES2896945T3 (es) 2022-02-28
EP2886129A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
DK2958588T3 (da) Kombination af vaccination og hæmning af PD-1-reaktionsvejen
DK3368069T3 (da) Anvendelse af myostatininhibitorer og kombinationsterapier
DK3283107T3 (da) Sammensætninger omfattende en kombination af ipilimumab og nivolumab
DK2882496T3 (da) Behandling og diagnosticering af melanom
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK2968208T3 (da) Behandling af kataplexi
DK3288553T3 (da) Kombinationer af cannabinoider og n-acylethanolaminer
DK3027618T3 (da) Polymorf af syk-hæmmere
DK3076972T3 (da) Cancerbehandling med kombination af plinabulin og taxan
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK2882441T3 (da) Behandling af immunrelaterede og inflammatoriske sygdomme
DK3071215T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3021838T3 (da) Behandling af fedme
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3099800T3 (da) Ekspression og oprensning af crm197 og beslægtede proteiner
DK3067355T3 (da) Krystaller af diazabicyclooctanderivat og fremgangsmåde til fremstilling af krystaller af diazabicyclooctanderivat
DK2723347T3 (da) Forebyggelse og behandling af inflammationstilstande
DK2981541T3 (da) Syntese og anvendelse af isotopmærkede glycaner
DK3280839T3 (da) Indretning til fremføring og spredning af stofstykker
DK3019167T3 (da) Behandling af forhøjede niveauer af eosinophiler og/eller basophiler
DK3033081T3 (da) Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3292873T3 (da) Kombination af vaccination og hæmning af PD-1-vejen